Background. Betaherpesviruses are established causes of morbidity and mortality in immunosuppressed patient groups but have been little studied in sub-Saharan Africa, the epicenter of the human immunodeficiency virus (HIV) pandemic. In this region, primary infections with human cytomegalovirus (HCMV) and human herpesvirus type 6 (HHV-6) type 6 are endemic in infancy, but the clinical impact of these infections among pediatric inpatient groups is poorly characterized and assumptive, based largely on data from Western populations.
and 7) are important causes of morbidity in children, and HCMV and HHV-6 are well-established causes of morbidity and mortality in immunocompromised patients [1, 2] , but they have been little studied in subSaharan Africa, the World Health Organization region with the highest pediatric disease burden and also the epicenter of the human immunodeficiency virus (HIV) pandemic. Primary HCMV and HHV-6 infections are endemic in African infants and children [3] [4] [5] , establishing lifelong latency with periodic reactivations or reinfections [1] . The great challenge in herpes virology is to differentiate active infections causing pathology from background subclinical viremia. To this end, the latest quantitative molecular diagnostics are being used to establish clinically informative viral load cutoffs in different patient groups and within different compartments, which can inform treatment [6] [7] [8] .
The betaherpesviruses are highly cell-associated and within vulnerable patient groups, detection of high HCMV and HHV-6 DNA loads in serum is indicative of active infections linked with poor outcomes [8, 9] , but absence or low viral loads in serum does not rule out localized infection restricted to specific compartments [10] .
Recent prospective studies and careful review of some older but overlooked studies has led to a growing awareness of the importance of HCMV infections in high-seroprevalence settings [11] [12] [13] , as a major cause of mortality in HIV-infected children [14, 15] and as a cause of developmental delay [5] and hearing loss [16] [17] [18] in children through either congenital or early infant infections, with maternal HIV infection and lower CD4 count associated with higher prevalence of congenital infection [15, 19] . HHV-6A, HHV-6B, and HHV-7 have been less well studied in sub-Saharan Africa. HHV-6B primary infection (and to a lesser extent, HHV-7) is the etiological agent of exanthema subitum, an endemic childhood illness characterized by fever, diarrhea, and skin rash [20, 21] , and is strongly associated with febrile seizures [22] including febrile status epilepticus [23] . HHV-6A is rarely found in children in Europe, the United States, and Japan, but a recent study found HHV-6A to be endemic in healthy Zambian infants [3] . Elsewhere, HHV-6A is more common in immunocompromised adults, and recent animal model studies have suggested possible roles for HHV-6A in immunodeficiency [24] and AIDS progression [25] . A study in US children also demonstrated an association between HHV-6B and AIDS progression [26] .
In sub-Saharan Africa, tertiary referral hospitals concentrate large numbers of seriously ill children from impoverished urban communities. At such centers, drugs to control HIV, tuberculosis, malaria, and other common bacterial, fungal, and parasite infections are broadly available, yet mortality rates remain high [27] . Rapid diagnostics and treatment for viral infections are broadly unavailable, but HCMV is an important cause of respiratory disease in HIV-infected African children [8, 14, 28, 29] , and HHV-6 and HHV-7 are possible causes of nonmalarial central nervous system (CNS) infections [30] . HCMV pneumonia can be treated successfully with intravenous ganciclovir in both immunocompromised (HIV-infected South African infants with confirmed HCMV infection) [28, 29] and immunocompetent children [31] . There are generic anticytomegalovirus drugs in the pipeline, and antibetaherpesvirus activity has been reported for several low-cost alternatives such as artesunate [32, 33] and the immunostimulant active hexose correlated compound [34] . Here we present data from a broad group of admitted children at the University Teaching Hospital in Lusaka, Zambia, with the aim of determining prevalence of betaherpesvirus DNAemia and viral loads, and identifying possible clinical associations and risk factors.
METHODS

Ethics Approval
The study was approved by the Biomedical Research Ethics Committee of the University of Zambia School of Medicine, Lusaka. The mothers/guardians of all participants gave written informed consent.
Study Design and Setting
We conducted a retrospective observational study to determine the prevalence, viral loads, and risk factors associated with betaherpesvirus DNAemia in admitted children at the University Teaching Hospital, Lusaka, Zambia. We selected biobanked sera specimens from children aged between 3 weeks and 2 years of age, admitted to the general pediatric inpatient wards, who had taken part in a tuberculosis diagnostic trial [35] , and screened them for all 4 betaherpesviruses and measured viral loads. The degree to which the recruited children were representative of the broader inpatient population was evaluated by comparing key demographic data with data from general admission records.
DNA Extraction and Polymerase Chain Reaction Analysis
Laboratory analysis was conducted in our dedicated 3-room molecular diagnostics laboratory. DNA from serum was extracted using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) as previously described [4, 15] . Extraction controls were included with every 11 samples. DNA extraction quality was monitored on every 11th sample using a Nanodrop (Thermo Fisher Scientific, Waltham, Massachusetts). Samples were tested for presence of HCMV, HHV-6A, HHV-6B, and HHV-7 using 3 different quantitative real-time TaqMan polymerase chain reaction (PCR) assays as described [7, 36, 37] . Oligonucleotide sequences and thermocycling conditions were as indicated (Table 1) . Realtime PCR was undertaken on a Rotor-Gene 6000 (Qiagen, Hilden, Germany). The fidelity of the PCR enzyme and purity of the DNA extraction was controlled through amplification of the housekeeping gene, β-actin, from every 11th sample. Positive (commercially produced standards), negative (molecular grade water), reagent (no template), and extraction controls were included with each run. HCMV genomic DNA was purchased from the National Institute for Biological Standards and Control (Potters Bar, United Kingdom). Genomic DNA for HHV-6A, HHV-6B, and HHV-7 were donated from the reagent repository of the HHV-6 Foundation (Santa Barbara, California). Standard curves for quantitation of betaherpesvirus viral loads were prepared as follows: for HCMV, lyophilized standard was resuspended in elution buffer according to the manufacturer's instructions to create a stock solution of 5 × 10 6 copies/mL. HHV-6A, HHV-6B, and HHV-7 standards were human sera containing 5 × 10 6 copies/mL. Two hundred microliters was extracted and reconstituted in 200 µL of elution buffer. For all 4 viruses, 10-fold serial dilutions were made down to 5 × 10 −1 copies/mL. Five microliters of each dilution (25 000, 2500, 250, 25, and 2.5 absolute copies) was then amplified in triplicate. The manufacturer's software was then used to generate standard curves against which cycle threshold values of clinical specimens were converted to copies per microliter of extracted DNA. Extracted DNA from clinical specimens was quantified (ng/µL) using a Nanodrop (Thermo Scientific), and viral genome equivalents per microgram of extracted DNA were calculated.
Statistical Analysis
Data analysis was undertaken using SPSS software, version 21 (IBM, Armonk, New York). Binary and continuous variables were compared by Pearson χ 2 test and Mann-Whitney U test respectively, between study groups and the general admitted population (Table 2 ). For under-or overrepresented covariates, weighting variables were calculated using the formula [ prevalence in hospital population / prevalence in sample] and then multiplied together and divided by the mean weight to make a composite weighting variable. This composite weight was then used to estimate hospital population-weighted prevalences for each of the betaherpesviruses. Multivariate binary logistic regression analysis (on nonweighted data) was used to evaluate possible associations between various clinical and demographic factors and betaherpesvirus infection and virus loads. The Wald-Wolfowitz runs test was used to evaluate the randomness of the distribution of positive samples. Median viral loads were compared by HIV status and underweight status using the Mann-Whitney U test. Step 1 @ 95°C, hold 10 s
Step 2 @ 58°C, hold 20 s
Step 3 @ 72°C, hold 1 s HHV-6A and HHV-6B [7] Forward primer GGAGTGCCTGTGGGTATTC Hold @ 94°C, 5 min
Reverse primer CTAAGGTGAGCCAGATTCG Cycling (55 repeats) HHV-6A probe: HEX-TGCAGCCATTTCTTTGGAAAGC-TAMRA
Step 1 @ 94°C, hold 15 s HHV-6B probe: FAM-TGCAGCCACCTCCTTGGAAAG-TAMRA
Step 2 @ 60°C, hold 60 s HHV-7 [36] Forward primer TTTCCTGTGACAAAAGAAGCAGTTA Hold @ 50°C, 2 min
Reverse primer ATCCCACACGCTTTACGGG Cycling (60 repeats) Probe: FAM-TTCCTGCGCAATAAAGTGAAAACTGTTAGCATT-TAMRA
Step 1 @ 95°C, hold 20 s
Step 2 @ 60°C, hold 60 s β-actin Forward primer: CACACTGTGCCCATCTACGA Hold 94°C 3 min Reverse primer: CTCAGTGAGGATCTTCATGAGGTAGT Cycling (45 cycles)
Probe: FAM-ATGCCCTCCCCCATGCCATCCTGCGT-TAMRA
Step 1 @ 94°C
Step 2 @ 65°C hold 50 s
Abbreviations: HCMV, human cytomegalovirus; HHV, human herpesvirus. 
RESULTS
Patient Recruitment
We screened DNA-extracted sera from 303 children aged between 3 weeks and 2 years of age. Median age was 12 months (interquartile range [IQR], 7-17 months), 42.5% of the children were female, 34.8% were HIV infected, and 36.3% were considered to be malnourished on admission (ie, admitted to the malnutrition ward due to weight-for-height z score < −2 or on clinical grounds at the discretion of the attending physician). Comparison with these routine admissions data showed that although sex was representative, the study children were significantly older, more likely to be HIV infected, and more likely to be malnourished (Table 2) , consistent with suspicion of tuberculosis or tuberculosis risk factors (HIV infection, household contact, etc), which were key inclusion criteria on the parent trial [35] .
Prevalence of Betaherpesvirus Infections
Betaherpesvirus DNAemia was detected by PCR in sera from 59.1% (179/303) of children ( Weighting for the overrepresentation of HIV-infected children, older median age, and increased prevalence of malnutrition did not significantly affect betaherpesvirus prevalence (Table 3) . HHV-6A was rare, with just 1 case-a male infant 9 months of age, admitted with suspected pneumonia, tuberculosis, or pertussis. A gastric aspirate was culture negative for tuberculosis; the baby was HIV negative and had a weight-for-age z score (WAZ) of −1.22. The mother reported recent loss of appetite and weight loss, fevers, productive cough, difficulties breathing, and lethargy. This baby was also positive for HCMV and HHV-7, 1 of just 9 babies positive for 3 betaherpesviruses. Fifty-two cases were coinfected with 2 viruses (Table 3) .
Risk Factors for Betaherpesvirus Infections
HCMV DNAemia was significantly more prevalent among HIV-infected children than among HIV-uninfected children (54.5% [55/ Table 4 ). Among 8 children admitted with suspected meningitis, 6 were positive for HCMV DNAemia (OR, 5.72; 95% CI, 1.07-30.5; P = .041). In our study group, betaherpesvirus DNAemia was not associated with fever (≥38°C), breastfeeding (an established route of transmission for HCMV, although only 13 children were not being, or had not been, breast fed), or reported recent rash (none of the children presented with a rash) ( Table 4) .
The odds of HCMV DNAemia decreased significantly with age (OR, 0.95; 95% CI, .91-.99; P = .008), with a similar trend for HHV-6B. Conversely, there was a trend for increased odds of HHV-7 DNAemia with age. To investigate these age trends in more detail, we plotted betaherpesvirus DNAemia prevalence by age in months ( Figure 1A ). We observed peaks of HCMV prevalence at 3-5 months and 18-20 months, indicative of early primary infection (with some residual DNAemia from congenital infections) followed by reactivation/reinfection in older children. A higher prevalence of HCMV DNAemia was associated with HIV infection ( Figure 1B ) and being underweight ( Figure 1C ) across all age groups. HHV-6B displayed a similar temporal profile to HCMV, with peaks suggestive of primary and secondary infections ( Figure 1A) . The temporal signature of HHV-7 DNAemia was clearly distinct from HCMV and HHV-6B, dropping from 20% to 10% over the first 6 months of life, but then steadily increasing back to 20% by 12 months, and remaining stable ( Figure 1A) . Coinfections with >1 betaherpesvirus were common, detected in 33.5% (60/179) of all cases (51 cases with 2 viruses, and 9 cases with 3 viruses), but HIV-infected children were no more likely to have a double or triple infection than HIV-uninfected children (data not shown). There was a significant correlation between HCMV and HHV-6B (Pearson correlation 0.157; P = .006), with HHV-6B DNAemia being associated with increased odds of HCMV DNAemia, controlled for HIV status, age, and WAZ score (OR, 2.20; 95% CI, 1.36-4.62; P = .003) (data not shown).
Viral Loads
Comparing viral loads, as defined by betaherpesvirus genome equivalents per microgram of extracted DNA, we found the highest viral loads for HHV-7 (median, 13 218 copies/µg DNA; IQR, 5185-25 195) followed by HCMV (median, 2993 copies/µg DNA; IQR, 991-10 630). HHV-6B median viral load was more than a log lower than that of HCMV (median, 91 copies/µg DNA; IQR, (Table 5 and Figure 2A [4] , which have also shown links with AIDS progression [38] and death [14] . The persistent association of HCMV infection with HIV infection and being underweight is consistent with a previous population-based study, which showed that early infant HCMV infection is independently linked with impaired physical development of Zambian children [5] .
The median HCMV viral load (3.9 log 10 copies/mL whole blood) was similar to a previous study of hospitalized Zambian children [4] . A recent South African study of HCMV pneumonia in infants used receiver operating characteristic analysis to determine that a viral load of 4.1 log 10 copies/mL whole blood could isolate 70% of cases with a positive urine culture [8] . Here we also analyzed copies per microgram of extracted DNA (normalizing for the amount of cell DNA present in the specimen) and found that although the range of viral loads was extremely broad, median HCMV viral load (copies/µg extracted DNA) was significantly higher (by 1 log) among HIV-infected children, an effect not evident for HHV-6 or HHV-7. Figure 1 . A, Betaherpesvirus prevalence stratified by age among admitted children <2 years of age. B, Human cytomegalovirus (HCMV) prevalence stratified by age and human immunodeficiency virus (HIV) status among admitted children. C, HCMV prevalence stratified by age and underweight among admitted children. Abbreviations: HHV, human herpesvirus; WAZ, weight-for-age z score. HCMV is an established cofactor linked with AIDS progression and neurological sequelae [38] , and so the association of HCMV infection with an admission diagnosis of meningitis is interesting and raises the question of to what degree HCMV is causing meningitis in African children, compared with bacterial pathogens, and whether it should be diagnosed and treated. A previous study also found that among HIV-exposed children (those who remain HIV negative but who have HIV-infected mothers), HCMV was linked with impaired psychomotor development [5] . Other reports from sub-Saharan Africa have identified both HCMV and HHV-6 among other viral infections as important causes of hospitalization and mortality among children with nonmalarial CNS infections [30, 39] . Studies have shown that detection of HCMV DNA in the CSF of patients with suspected meningitis is associated with mortality in both adults [40, 41] and children [42] .
With respect to HHV-6B, our findings are consistent with a large study from the United States that demonstrated active HHV-6 infection in 20% of infants admitted with febrile illness [22] . Previous studies from Zambia with smaller sample sizes have detected HHV-6 DNA in the whole blood of 5%-30% of children admitted with febrile illness [3, 43] . Classical sequencing over a hypervariable region within the U47 locus identified HHV-6A in 37.5%-57% of those that were successfully sequenced [3, 43] . This indication that HHV-6A might be a prevalent infant infection in Africa was followed up by a population-based study of healthy children, which identified HHV-6A in 99% (55/56) (of which 7 cases were coinfected with HHV-6B) and HHV-6B in 15% (8/56) of infants in which HHV-6 was detected and successfully typed [3] . In light of these previous findings, we were surprised to find such a low prevalence of HHV-6A. We detected HHV-6A and HHV-6B using a highly sensitive and specific multiplex TaqMan-based real-time PCR assay with conserved primers but species-specific probes targeting the HHV-6 DNA polymerase gene (U38) [7] . In coinfected patients, the use of conserved primers may result in the masking of the species with lower copy number, but this alone is unlikely to explain the stark contrast between the 2 studies. There is some limited evidence within the U47 gene for isolates containing both HHV-6A and HHV-6B elements [3, 44] , although globally, complete genomic sequences for HHV-6 have only been published for 4 strains: [45] [46] [47] [48] [49] [50] [51] [52] . HHV-6 is integrated into the telomeric repeats of roughly 1% of European and 0.2% of Japanese populations, typically characterized by high loads of HHV-6 DNA in clinical samples [53] . None of the HHV-6-positive samples on this study displayed viral loads (5 log/µg DNA) that might be consistent with chromosomal integration [54] .
The distribution of betaherpesvirus prevalence by age showed profiles indicative of early primary infection with HCMV and HHV-6B peaking between 3 and 6 months of age, followed by secondary infection or reactivation in children >12 months of age. For HCMV this is consistent with previous African studies [5] but different from high-income populations where HCMV infection occurs later [55] . For HHV-6B, our data are consistent with a US study [22] . The distribution of HHV-7 infections was distinct from HCMV and HHV-6B, with most primary infections appearing to occur in young neonates, followed by a steady increase in probable reactivated infections during the first year of life, and a very stable prevalence of around 20% among admitted children >12 months of age. We present the first data on HHV-7 infections in African children, and the age distribution is consistent with serological data from Brazil [56], yet contrary to US data, which suggest that primary infection with HHV-7 peaks later than HHV-6B [57] .
There were several limitations to this study: Analysis of a single serum sample prevents detailed determination of the clinical and virological course of individual betaherpesvirus infections. The diagnostic tests used cannot accurately differentiate between active infections causal of pathology, and subclinical DNAemia arising from reactivated infections secondary to other infections and diseases. Similarly, in the absence of serological data we cannot confirm whether individual infections were primary or secondary, although we could infer some indication of the presence of primary and secondary infections from the age distribution. The use of commercial assays would have greatly strengthened comparisons of prevalence and viral loads with other studies. We did not have access to maternal HIV status preventing comparison of the relevance of HCMV infections in HIV-exposed children, seen in previous studies [5] , and could not determine how many of the infections were acquired in utero. We did not have infant height data and so could not calculate z scores for stunting and wasting, which are more accurate markers of growth delay than underweight (WAZ).
Despite these limitations, our findings add weight to previous studies which demonstrate that HCMV infections (both congenital [15, 16, 19] and infant infections [5, 8, 14, 28, 29] ) are emerging as important determinants of health and development in African children.
Notes
